Insulin aspart, recombinant Subcutaneous and Maprotiline Hydrochloride
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Maprotiline Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: maprotiline
Brand name: Ludiomil
Synonyms: Maprotiline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Mar-cof BP
- Insulin aspart, recombinant Subcutaneous-Mar-cof CG
- Insulin aspart, recombinant Subcutaneous-Maraviroc
- Insulin aspart, recombinant Subcutaneous-Maraviroc Oral Solution
- Insulin aspart, recombinant Subcutaneous-Maraviroc Tablets
- Insulin aspart, recombinant Subcutaneous-Marcaine
- Maprotiline Hydrochloride-Insulin degludec
- Maprotiline Hydrochloride-Insulin Degludec (U-100) Prefilled Pens
- Maprotiline Hydrochloride-Insulin Degludec (U-100) Vials
- Maprotiline Hydrochloride-Insulin Degludec (U-200) Prefilled Pens
- Maprotiline Hydrochloride-Insulin degludec and liraglutide
- Maprotiline Hydrochloride-Insulin degludec and liraglutide Subcutaneous